| Year |
Title |
Altmetric |
| 2016
|
The effects of differences in pspA alleles and capsular types on the resistance of Streptococcus pneumoniae to killing by apolactoferrin.
Microbial Pathogenesis.
99:209-219.
2016
|
|
| 2016
|
Monoclonal antibodies to Shigella lipopolysaccharide are useful for vaccine production.
Clinical and Vaccine Immunology.
23:681-688.
2016
|
|
| 2016
|
Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile.
BMC Microbiology.
16.
2016
|
|
| 2016
|
Discovery and characterization of human-urine utilization by asymptomaticbacteriuria-causing Streptococcus agalactiae.
Infection and Immunity.
84:307-319.
2016
|
|
| 2015
|
Loss of vancomycin-resistant enterococcus fecal dominance in an organ transplant patient with Clostridium difficile colitis after fecal microbiota transplant.
Open Forum Infectious Diseases.
2.
2015
|
|
| 2014
|
Copper complexation screen reveals compounds with potent antibiotic properties against methicillin-resistant Staphylococcus aureus.
Antimicrobial Agents and Chemotherapy.
58:3727-3736.
2014
|
|
| 2013
|
Asymptomatic bacteriuria: Prevalence rates of causal microorganisms, etiology of infection in different patient populations, and recent advances in molecular detection.
FEMS Microbiology Letters.
346:1-10.
2013
|
|
| 2013
|
Erratum: Diversity of group B streptococcus serotypes causing urinary tract infection in adults (Journal of Clinical Microbiology (2009) 47:7 (2055-2060)).
Journal of Clinical Microbiology.
51:2806.
2013
|
|
| 2012
|
Prognostic value of semi-quantitative bacteruria counts in the diagnosis of group B streptococcus urinary tract infection: a 4-year retrospective study in adult patients.
BMC Infectious Diseases.
12.
2012
|
|
| 2012
|
Device for carrying blood samples at 37°C for cryoglobulin test.
Clinical and Vaccine Immunology.
19:1555-1556.
2012
|
|
| 2012
|
Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection.
Infection and Immunity.
80:3145-3160.
2012
|
|
| 2012
|
Group B streptococcus cystitis presenting in a diabetic patient with a massive abdominopelvic abscess: A case report.
Journal of Medical Case Reports.
6.
2012
|
|
| 2011
|
Development of an automated and multiplexed serotyping assay for Streptococcus pneumoniae.
Clinical and Vaccine Immunology.
18:1900-1907.
2011
|
|
| 2011
|
Serine protease PrtA from Streptococcus pneumoniae plays a role in the killing of S. pneumoniae by apolactoferrin.
Infection and Immunity.
79:2440-2450.
2011
|
|
| 2010
|
Hit-and-run stimulation: A novel concept to reactivate latent HIV-1 infection without cytokine gene induction.
Journal of Virology.
84:8712-8720.
2010
|
|
| 2010
|
Group B Streptococcus (GBS) urinary tract infection involves binding of GBS to bladder uroepithelium and potent but GBS-specific induction of interleukin 1α.
Journal of Infectious Diseases.
201:866-870.
2010
|
|
| 2009
|
Diversity of group B streptococcus serotypes causing urinary tract infection in adults.
Journal of Clinical Microbiology.
47:2055-2060.
2009
|
|
| 2008
|
PIR-B-deficient mice are susceptible to Salmonella infection.
Journal of Immunology.
181:4229-4239.
2008
|
|
| 2006
|
Risk of infection and tracking of work-related infectious diseases in the funeral industry.
American Journal of Infection Control.
34:655-660.
2006
|
|
| 2006
|
Case report: Severe hemolytic disease of the newborn in a group B African-American infant delivered by a group O mother.
Annals of Clinical and Laboratory Science.
36:205-207.
2006
|
|
| 2006
|
Validation of a multiplex pneumococcal serotyping assay with clinical samples.
Journal of Clinical Microbiology.
44:383-388.
2006
|
|
| 2006
|
Severe hemolytic disease of the newborn in a group B African-American infant delivered by a group O mother..
Annals of Clinical and Laboratory Science.
36:205-207.
2006
|
|
| 2005
|
Antibodies to the pneumococcal surface protein A, PspA, can be produced in splenectomized mice and can protect splenectomized mice from infection with Streptococcus pneumoniae.
Vaccine.
23:4257-4262.
2005
|
|
| 2005
|
Long-term molecular analysis of tuberculosis strains in Alabama, a state characterized by a largely indigenous, low-risk population.
Journal of Clinical Microbiology.
43:870-878.
2005
|
|
| 2005
|
Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity.
Journal of Clinical Investigation.
115:66-75.
2005
|
|
| 2005
|
Rapid multiplex assay for serotyping pneumococci with monoclonal and polyclonal antibodies.
Journal of Clinical Microbiology.
43:156-162.
2005
|
|
| 2005
|
Relative fitness of fluoroquinolone-resistant Streptococcus pneumoniae
2005
|
|
| 2004
|
Erratum: PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin (Infection and Immunity (2004) 72, 9 (5031-5040)).
Infection and Immunity.
72:7379.
2004
|
|
| 2004
|
Lipoprotein PsaA in virulence of Streptococcus pneumoniae: Surface accessibility and role in protection from superoxide.
Infection and Immunity.
72:5858-5867.
2004
|
|
| 2004
|
PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin.
Infection and Immunity.
72:5031-5040.
2004
|
|
| 2003
|
Dissemination of Macrolide-Resistant Streptococcus pneumoniae Isolates Containing Both erm(B) and mef(A) in South Korea.
Journal of Clinical Microbiology.
41:5787-5791.
2003
|
|
| 2003
|
Evaluation of an extensive tuberculosis contact investigation in an urban community and jail.
International Journal of Tuberculosis and Lung Disease.
7.
2003
|
|
| 2003
|
The Rapid Development of Fluoroquinolone Resistance in M. tuberculosis [7].
New England Journal of Medicine.
349:1977-1978.
2003
|
|
| 2003
|
Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae.
Journal of Infectious Diseases.
188:339-348.
2003
|
|
| 2003
|
Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides.
Clinical and Vaccine Immunology.
10:514-519.
2003
|
|
| 2003
|
Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America.
Journal of Clinical Microbiology.
41:2458-2464.
2003
|
|
| 2003
|
Vancomycin-resistant enterococci: 15 years and counting.
Journal of Hospital Infection.
53:159-171.
2003
|
|
| 2003
|
Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci.
2003
|
|
| 2003
|
Ligase chain reaction..
Methods in Molecular Biology.
226:135-150.
2003
|
|
| 2002
|
Evidence for Epstein-Barr virus autoantibodies against human brain in demyelinating encephalitis.
Neuropathology and Applied Neurobiology.
28:498-501.
2002
|
|
| 2002
|
Cross-jurisdictional transmission of Mycobacterium tuberculosis in Maryland and Washington, D.C., 1996-2000, linked to the homeless
2002
|
|
| 2002
|
Molecular differentiation of Mycobacterium tuberculosis strains without IS6110 insertions
2002
|
|
| 2002
|
Molecular epidemiology of tuberculosis in a low-to moderate-incidence state: Are contact investigations enough?
2002
|
|
| 2002
|
Molecular epidemiology of tuberculosis in a sentinel surveillance population
2002
|
|
| 2002
|
Molecular typing of Mycobacterium tuberculosis strains with a common two-band IS6110 pattern
2002
|
|
| 2002
|
Expression, autoregulation, and DNA binding properties of the Mycobacterium tuberculosis TrcR response regulator.
Journal of Bacteriology.
184:2192-2203.
2002
|
|
| 2001
|
In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of children.
International Journal of Antimicrobial Agents.
18:531-535.
2001
|
|
| 2001
|
Clinical isolates of Streptococcus pneumoniae resistant to levofloxacin contain mutations in both gyrA and parC genes.
International Journal of Antimicrobial Agents.
18:373-378.
2001
|
|
| 2001
|
Epidemiologic usefulness of spoligotyping for secondary typing of Mycobacterium tuberculosis isolates with low copy numbers of IS6110.
Journal of Clinical Microbiology.
39:3709-3711.
2001
|
|
| 2001
|
Identification of a contaminating Mycobacterium tuberculosis strain with a transposition of an IS6110 insertion element resulting in an altered spoligotype.
Journal of Clinical Microbiology.
39:1092-1096.
2001
|
|
| 2001
|
Direct identification of Mycobacterium avium complex and Mycobacterium gordonae from MB/BacT bottles using accuprobe.
Journal of Clinical Microbiology.
39:570-573.
2001
|
|
| 2001
|
Value of Mycobacterium tuberculosis fingerprinting as a tool in a rural state surveillance program.
Chest.
120:1877-1882.
2001
|
|
| 2000
|
The MB/BacT is a sensitive method of isolating Mycobacterium tuberculosis from clinical specimens in a laboratory with a low rate of isolation [2] (multiple letters).
Journal of Clinical Microbiology.
38:3133-3134.
2000
|
|
| 2000
|
Human C-reactive protein is protective against fatal Salmonella enterica serovar Typhimurium infection in transgenic mice.
Infection and Immunity.
68:5652-5656.
2000
|
|
| 2000
|
Use of clindamycin disks to detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children.
Journal of Clinical Microbiology.
38:1731-1734.
2000
|
|
| 1999
|
Spot sputum screening: Evaluation of an intervention in two homeless shelters.
International Journal of Tuberculosis and Lung Disease.
3:613-619.
1999
|
|
| 1999
|
Comparison of direct inoculation and Copan transport systems for isolation of Neisseria gonorrhoeae from endocervical specimens.
Journal of Clinical Microbiology.
37:3583-3585.
1999
|
|
| 1999
|
In vitro evidence of two-component system phosphorylation between the Mycobacterium tuberculosis TrcR/TrcS proteins.
Microbial Pathogenesis.
26:195-206.
1999
|
|
| 1998
|
Restriction fragment length polymorphism screening of Mycobacterium tuberculosis isolates: Population surveillance for targeting disease transmission in a community.
International Journal of Tuberculosis and Lung Disease.
2:655-662.
1998
|
|
| 1998
|
Comparison of the MB/BacT system with a revised antibiotic supplement kit to the BACTEC 460 system for detection of mycobacteria in clinical specimens.
Journal of Clinical Microbiology.
36:3234-3238.
1998
|
|
| 1997
|
Avirulence of LT2 strains of Salmonella typhimurium results from a defective rpoS gene.
Infection and Immunity.
65:2451-2453.
1997
|
|
| 1997
|
Bacterial phenotypes mediated by mviA and their relationship to the mouse virulence of Salmonella typhimurium.
Microbial Pathogenesis.
22:353-362.
1997
|
|
| 1996
|
Transmission of mycobacterium tuberculosis to recipients of single lung transplants from the same donor.
Pneumologie.
50:733.
1996
|
|
| 1996
|
Acid shock induction of RpoS is mediated by the mouse virulence gene mviA of Salmonella typhimurium.
Journal of Bacteriology.
178:2572-2579.
1996
|
|
| 1996
|
Immunoprotection by monoclonal antibodies to the porins and lipopolysaccharide of Salmonella typhimurium.
Microbial Pathogenesis.
21:249-263.
1996
|
|
| 1996
|
The predicted amino acid sequence of the Salmonella typhimurium virulence gene mviA+ strongly indicates that MviA is a regulator protein of a previously unknown S. typhimurium response regulator family.
Infection and Immunity.
64:2365-2367.
1996
|
|
| 1996
|
Transmission of Mycobacterium tuberculosis to recipients of single lung transplants from the same donor.
American Journal of Respiratory and Critical Care Medicine.
153:1166-1168.
1996
|
|
| 1995
|
Laboratory contamination of Mycobacterium tuberculosis cultures.
American Journal of Respiratory and Critical Care Medicine.
152:1702-1704.
1995
|
|
| 1994
|
Mouse Virulence Gene A (mviA+) Is a Pleiotropic Regulator of Gene Expression in Salmonella typhimurium.
Annals of the New York Academy of Sciences.
730:295-296.
1994
|
|
| 1994
|
The intracellular nature of Salmonella infection during the early stages of mouse typhoid..
Immunology series.
60:303-312.
1994
|
|
| 1993
|
In vivo administration of the anticancer agent bryostatin 1 activates platelets and neutrophils and modulates protein kinase C activity..
Cancer Research.
53:2810-2815.
1993
|
|
| 1992
|
A 'safe-site' for Salmonella typhimurium is within splenic polymorphonuclear cells.
Microbial Pathogenesis.
13:181-190.
1992
|
|
| 1992
|
Detection of DNA in southern blots by chemiluminescence is a sensitive and rapid technique
1992
|
|
| 1992
|
In Vivo Administration of Bryostatin 1, a Protein Kinase C Activator, Decreases Murine Resistance to Salmonella typhimurium.
Cancer Research.
52:2143-2147.
1992
|
|
| 1991
|
The salmonella typhlmurium locus mv/a regulates virulence in itys but not ityr mice: Functional mv/a results in avirulence; mutant (nonfunctional) mv/a results in virulence.
Journal of Experimental Medicine.
174:1073-1083.
1991
|
|
| 1991
|
A 'safe-site' for Salmonella typhimurium is within splenic cells during the early phase of infection in mice.
Microbial Pathogenesis.
10:297-310.
1991
|
|
| 1991
|
A hemA mutation renders Salmonella typhimurium avirulent in mice, yet capable of eliciting protection against intravenous infection with S. typhimurium.
Microbial Pathogenesis.
11:289-295.
1991
|
|
| 1991
|
Mouse hepatitis virus strain UAB infection enhances resistance to Salmonella typhimurium in mice by inducing suppression of bacterial growth.
Infection and Immunity.
59:852-856.
1991
|
|
| 1990
|
The primary effect of the Ity locus is on the rate of growth of Salmonella typhimurium that are relatively protected from killing.
Journal of Immunology.
144:3143-3151.
1990
|
|
| 1989
|
Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens.
Infection and Immunity.
57:1457-1464.
1989
|
|
| 1989
|
Modulation of resistance to Salmonella typhimurium infection in mice by mouse hepatitis virus (MHV).
Microbial Pathogenesis.
6:81-91.
1989
|
|
| 1986
|
Effects of in vitro growth phase on the pathogenesis of Salmonella typhimurium in mice.
Microbiology.
132:1283-1295.
1986
|
|
| 1986
|
Genetic approaches to the study of disease resistance: with special emphasis on the use of recombinant inbred mice..
Current Topics in Microbiology and Immunology.
124:21-35.
1986
|
|
| 1986
|
Genetic control of the susceptibility to pneumococcal infection..
Current Topics in Microbiology and Immunology.
124:103-120.
1986
|
|
| 1986
|
Genetic mapping of novel virulence determinants of Salmonella typhimurium to the region between trpD and supD.
Microbial Pathogenesis.
1:115-124.
1986
|
|
| 1986
|
Independence of macrophage activation and expression of the alleles of the Ity (immunity to typhimurium) locus.
Microbial Pathogenesis.
1:33-41.
1986
|
|
| 1986
|
Salmonella typhimurium virulence genes necessary to exploit the Ity(s/s) genotype of the mouse.
Infection and Immunity.
51:872-878.
1986
|
|
| 1985
|
Induction of germ-line anti-α1-3 dextran antibody responses in mice by members of the enterobacteriaceae family.
Journal of Immunology.
135:3468-3472.
1985
|
|
| 1985
|
The ability of Salmonella typhimurium to produce the siderophore enterobactin is not a virulence factor in mouse typhoid.
Infection and Immunity.
50:392-397.
1985
|
|
| 1984
|
Blood clearance by anti-phosphocholine antibodies as a mechanism of protection in experimental pneumococcal bacteremia.
Journal of Immunology.
133:3308-3312.
1984
|
|
| 1981
|
A genetic locus responsible for salmonella susceptibility in BSVS mice is not responsible for the limited T-dependent immune responsiveness of BSVS mice.
Journal of Immunology.
127:906-911.
1981
|
|
